CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 82 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 1.90 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $63,754 | -25.3% | 49,421 | -0.4% | 0.04% | -26.5% |
Q2 2023 | $85,306 | +113.9% | 49,596 | +87.8% | 0.05% | +133.3% |
Q1 2023 | $39,884 | +0.6% | 26,412 | +6.6% | 0.02% | 0.0% |
Q4 2022 | $39,660 | -44.1% | 24,787 | -48.2% | 0.02% | -44.7% |
Q3 2022 | $71,000 | +6.0% | 47,869 | +33.3% | 0.04% | +18.8% |
Q2 2022 | $67,000 | +67.5% | 35,919 | +145.3% | 0.03% | +113.3% |
Q1 2022 | $40,000 | -35.5% | 14,644 | +6.5% | 0.02% | -28.6% |
Q4 2021 | $62,000 | -8.8% | 13,744 | +2.6% | 0.02% | -16.0% |
Q3 2021 | $68,000 | – | 13,394 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,877,148 | $13,853,000 | 1.46% |
Congress Park Capital LLC | 167,811 | $1,238,000 | 1.04% |
Perceptive Advisors | 3,253,923 | $24,014,000 | 0.65% |
RTW INVESTMENTS, LP | 990,463 | $7,310,000 | 0.44% |
Spark Investment Management LLC | 337,164 | $2,488,000 | 0.32% |
Exane Asset Management | 54,065 | $399,000,000 | 0.31% |
DAFNA Capital Management LLC | 100,000 | $738,000 | 0.28% |
HARBOURVEST PARTNERS LLC | 79,193 | $584,000 | 0.24% |
WELD CAPITAL MANAGEMENT LLC | 86,363 | $637,000 | 0.12% |
GSA CAPITAL PARTNERS LLP | 77,997 | $576,000 | 0.08% |